Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas systems have revolutionized genetic engineering, offering a precise and efficient platform for genome editing.  This review explores the mechanisms of CRISPR-Cas systems, focusing primarily on the widely utilized CRISPR-Cas9 system, and its applications across diverse fields.  While initially derived from bacterial adaptive immune systems, CRISPR-Cas9's programmable nature allows for targeted modification of DNA sequences in virtually any organism, offering unprecedented opportunities in biomedical research and therapeutic development.  This paper will critically evaluate the advantages and limitations of CRISPR-Cas9, including its off-target effects, delivery challenges, and ethical implications.  We will further discuss advancements in CRISPR technology, such as base editing and prime editing, which aim to mitigate some of these limitations and enhance precision.  Finally, we will examine the current and future applications of CRISPR technology, ranging from gene therapy for inherited diseases and cancer treatment to agricultural improvements and synthetic biology. This comprehensive review highlights the transformative potential of CRISPR technology while acknowledging the critical considerations surrounding its responsible development and deployment.